Fundz

Cullinan Oncology Completes $98.5 Million Series B Financing

PRIVATEJun 04, 2020

Amount Raised

$98 Million

Round Type

Series B

United StatesHealthcare

Description

Cullinan Oncology, LLC announced today the closing of a $98.5 million Series B financing, which will be used to support ongoing clinical trials across its small molecule and biologics portfolio. New institutional investors and family offices participated in the financing alongside original commitments from founding investors MPM Capital and F2 Ventures. Following the completion of the fundraising, Tim Anderson of Cowen Healthcare investments (CHI) has joined the Board.

Quick answer

Cullinan Oncology raised $98 Million in a Series B round, dated June 4, 2020. Cullinan Oncology is based in United States.

How much did Cullinan Oncology raise?
Cullinan Oncology raised $98 Million in a Series B round on June 4, 2020.
What does Cullinan Oncology do?
Cullinan’s business model is predicated on distributing risk while maximizing optionality inherent in novel science through the construction of a diversified portfolio of internally developed as well as externally..
Where is Cullinan Oncology based and how big is it?
Cullinan Oncology is based in United States.
Who are the decision-makers at Cullinan Oncology?
Fundz holds 1 contact at Cullinan Oncology. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as Cullinan Oncology that raised within 45 days of this round, from Fundz verified event records.

  • VersaPeutics, Inc. raised an undisclosed amount on July 17, 2020.
  • Can-Fite BioPharma Ltd. raised $3.4M (Seed) on July 17, 2020.
  • Pure Scientific Technologies Inc. raised $500K (Seed) on July 17, 2020.
  • Evolus raised $40M on July 17, 2020.
  • Preventice Solutions, Inc. raised $45M on July 16, 2020.
  • NewIV Medical Corp raised $2.8M (Seed) on July 16, 2020.

Who to call at Cullinan Oncology, and when

A new round usually means Cullinan Oncology is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Cullinan Oncology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cullinan Oncology, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cullinan Oncology. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cullinan Oncology

Location

United States

About

Cullinan’s business model is predicated on distributing risk while maximizing optionality inherent in novel science through the construction of a diversified portfolio of internally developed as well as externally sourced oncology assets. Cullinan’s scalable model minimizes the fixed costs and inefficiencies of many traditional development approaches through strategic partnerships and a shared services platform. For more information, visit www.cullinanoncology.com

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cullinan Oncology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts6 people are listed at Cullinan Oncology. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Cullinan Oncology's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Cullinan Oncology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.